Multibic 2 Potassium Solution 5L

Adult administration

1) In cases of acute renal failure, a dosage of 2,000 mL/h based on a 70 kg adult is appropriate for waste removal, depending on the patient's metabolic level. The dosage should be adjusted according to the patient's body weight. 2) The dosage and duration for blood dialysis, hemofiltration, and dialysis filtration needed for treating acute intoxication symptoms should be determined based on toxin concentration and clinical severity. 3) The maximum recommended dosage is 75 L per day.

This medication should not be used in certain patients. It should not be administered to patients who are allergic to any of its components, have low potassium levels, metabolic alkalosis with high blood acidity, or patients with excessive metabolism or inadequate blood supply, and those at high risk of bleeding. Gastrointestinal issues such as nausea or vomiting, blood pressure changes, muscle cramps, fluid imbalance, and electrolyte abnormalities may occur with this medication. Additionally, if there is either excess or insufficient fluid, symptoms such as shortness of breath, leg swelling, dizziness, and thirst may appear. While using this medication, potassium, sodium, calcium, magnesium, phosphate, and glucose levels in the blood should be frequently monitored, and fluid status must be observed carefully. If hypokalemia or hyperkalemia occurs, appropriate measures are required. Furthermore, this medication may not adequately supplement certain essential nutrients during hemodialysis or hemofiltration; if needed, nutritional supplementation may be required. Care should be taken for interactions when used with other medications, particularly with cardiac medications such as digitalis which may increase toxicity. Caution is also advised when taking vitamin D or calcium-containing preparations, as calcium levels may become excessively high. Pregnant or nursing women are advised against using this medication, and it is also not recommended for children as safety has not been adequately established. In the event of overdose, severe fluid and electrolyte imbalances may occur, which could lead to heart or lung problems, so immediate consultation with medical personnel is necessary. This medication must be mixed before use, heated to a temperature similar to body temperature, and the solution should be frequently checked for precipitates. If precipitation is found, the solution and tubing must be replaced promptly, and the patient should be carefully monitored. When stored, the mixed solution should be used within 48 hours at or below 30 degrees Celsius, and it is recommended to administer it immediately after use. This medication is known not to affect driving or machine operation abilities.

Serious side effects

Shortness of breath, ankle and leg swelling, congestive heart failure and/or pulmonary congestion

Mild side effects

Nausea, vomiting, hypotension, hypertension, muscle cramps, fluid overload, dehydration, electrolyte imbalances (such as hypokalemia), hypophosphatemia, hyperglycemia, metabolic alkalosis, hematological abnormalities (abnormal serum concentrations), dizziness, thirst, blood pressure changes, heart rate changes, changes in pulmonary arterial pressure, calcium carbonate precipitation observed.

This medication should be stored in sealed containers to avoid air exposure, in a cool place between 4 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance

Colorless and transparent liquid formulation contained in a clear plastic bag

Package unit

200 bags/box [5,000 mL per bag]